EN

Investors

Ace Biopharm financials, revenue trend and balance sheet

Financial Highlights

Unit: KRW 100 Million

Revenue by year (KRW 100 million): 2019 713, 2020 765, 2021 863, 2022 1,003, 2023 1,080, 2024 1,210, 2025 1,277

Financial Position

(As of 2025-12 · unit: KRW million)

Balance sheet. The table gives the item and the amount.
ItemAmount
Current assets45,263
Non-current assets36,356
Total assets81,619
Current liabilities45,240
Non-current liabilities5,946
Total liabilities51,186
Capital500
Retained earnings21,726
Total equity30,433